Kromek Group PLC (AIM:KMK) has secured repeat orders for its cadmium zinc telluride-based detectors from three medical imaging customers worth a total of US$1.1mln (£900,000) in the group's key target market of single photon emission computed tomography (SPECT).
The orders comprise:
- US$300,000 award for detectors for niche SPECT applications, which is expected to be delivered during the biotechnology company’s current financial year
- US$563,000 order from an OEM for niche SPECT applications
- US$205,000 order for niche medical imaging applications
The two latter orders are both from long-term customers of Kromek with delivery due to commence during the current financial year for completion in the first half of the 2024 financial year.
Chief executive Arnab Basu said: "Receiving these orders from long-term customers in the medical imaging market highlights the regular, repeat nature of business in the advanced imaging segment, which is a real strength for Kromek.
“The growth in demand from both new and existing customers reinforces the board's continued confidence in our prospects in this market.”